List of Tables
Table 1. Global Ofatumumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Ofatumumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Ofatumumab Market Competitive Situation by Manufacturers in 2023
Table 4. Global Ofatumumab Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Ofatumumab Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Ofatumumab Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Ofatumumab Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Ofatumumab Average Price (US$/Kg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Ofatumumab, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ofatumumab, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ofatumumab, Product Type & Application
Table 12. Global Key Manufacturers of Ofatumumab, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ofatumumab by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ofatumumab as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ofatumumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Ofatumumab Sales by Region (2019-2024) & (Kg)
Table 18. Global Ofatumumab Sales Market Share by Region (2019-2024)
Table 19. Global Ofatumumab Sales by Region (2025-2030) & (Kg)
Table 20. Global Ofatumumab Sales Market Share by Region (2025-2030)
Table 21. Global Ofatumumab Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Ofatumumab Revenue Market Share by Region (2019-2024)
Table 23. Global Ofatumumab Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Ofatumumab Revenue Market Share by Region (2025-2030)
Table 25. North America Ofatumumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Ofatumumab Sales by Country (2019-2024) & (Kg)
Table 27. North America Ofatumumab Sales by Country (2025-2030) & (Kg)
Table 28. North America Ofatumumab Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Ofatumumab Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Ofatumumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Ofatumumab Sales by Country (2019-2024) & (Kg)
Table 32. Europe Ofatumumab Sales by Country (2025-2030) & (Kg)
Table 33. Europe Ofatumumab Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Ofatumumab Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Ofatumumab Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Ofatumumab Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Ofatumumab Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Ofatumumab Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Ofatumumab Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Ofatumumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Ofatumumab Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Ofatumumab Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Ofatumumab Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Ofatumumab Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Ofatumumab Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Ofatumumab Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Ofatumumab Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Ofatumumab Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Ofatumumab Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Ofatumumab Sales (Kg) by Type (2019-2024)
Table 51. Global Ofatumumab Sales (Kg) by Type (2025-2030)
Table 52. Global Ofatumumab Sales Market Share by Type (2019-2024)
Table 53. Global Ofatumumab Sales Market Share by Type (2025-2030)
Table 54. Global Ofatumumab Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Ofatumumab Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Ofatumumab Revenue Market Share by Type (2019-2024)
Table 57. Global Ofatumumab Revenue Market Share by Type (2025-2030)
Table 58. Global Ofatumumab Price (US$/Kg) by Type (2019-2024)
Table 59. Global Ofatumumab Price (US$/Kg) by Type (2025-2030)
Table 60. Global Ofatumumab Sales (Kg) by Application (2019-2024)
Table 61. Global Ofatumumab Sales (Kg) by Application (2025-2030)
Table 62. Global Ofatumumab Sales Market Share by Application (2019-2024)
Table 63. Global Ofatumumab Sales Market Share by Application (2025-2030)
Table 64. Global Ofatumumab Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Ofatumumab Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Ofatumumab Revenue Market Share by Application (2019-2024)
Table 67. Global Ofatumumab Revenue Market Share by Application (2025-2030)
Table 68. Global Ofatumumab Price (US$/Kg) by Application (2019-2024)
Table 69. Global Ofatumumab Price (US$/Kg) by Application (2025-2030)
Table 70. BOC Sciences Corporation Information
Table 71. BOC Sciences Description and Business Overview
Table 72. BOC Sciences Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 73. BOC Sciences Ofatumumab Product
Table 74. BOC Sciences Recent Developments/Updates
Table 75. GlaxoSmithKline(GSK) Corporation Information
Table 76. GlaxoSmithKline(GSK) Description and Business Overview
Table 77. GlaxoSmithKline(GSK) Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 78. GlaxoSmithKline(GSK) Ofatumumab Product
Table 79. GlaxoSmithKline(GSK) Recent Developments/Updates
Table 80. Lonza Group Corporation Information
Table 81. Lonza Group Description and Business Overview
Table 82. Lonza Group Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 83. Lonza Group Ofatumumab Product
Table 84. Lonza Group Recent Developments/Updates
Table 85. Novartis International Corporation Information
Table 86. Novartis International Description and Business Overview
Table 87. Novartis International Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 88. Novartis International Ofatumumab Product
Table 89. Novartis International Recent Developments/Updates
Table 90. TargetMol Chemicals Corporation Information
Table 91. TargetMol Chemicals Description and Business Overview
Table 92. TargetMol Chemicals Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 93. TargetMol Chemicals Ofatumumab Product
Table 94. TargetMol Chemicals Recent Developments/Updates
Table 95. Hubei Kele Fine Chemical Corporation Information
Table 96. Hubei Kele Fine Chemical Description and Business Overview
Table 97. Hubei Kele Fine Chemical Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 98. Hubei Kele Fine Chemical Ofatumumab Product
Table 99. Hubei Kele Fine Chemical Recent Developments/Updates
Table 100. Jiangxi Ruiweier Biotechnology Corporation Information
Table 101. Jiangxi Ruiweier Biotechnology Description and Business Overview
Table 102. Jiangxi Ruiweier Biotechnology Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 103. Jiangxi Ruiweier Biotechnology Ofatumumab Product
Table 104. Jiangxi Ruiweier Biotechnology Recent Developments/Updates
Table 105. Nantong Feiyu Biological Technology Corporation Information
Table 106. Nantong Feiyu Biological Technology Description and Business Overview
Table 107. Nantong Feiyu Biological Technology Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 108. Nantong Feiyu Biological Technology Ofatumumab Product
Table 109. Nantong Feiyu Biological Technology Recent Developments/Updates
Table 110. Shanghai Biochempartner Corporation Information
Table 111. Shanghai Biochempartner Description and Business Overview
Table 112. Shanghai Biochempartner Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 113. Shanghai Biochempartner Ofatumumab Product
Table 114. Shanghai Biochempartner Recent Developments/Updates
Table 115. Shanghai Macklin Biochemical Corporation Information
Table 116. Shanghai Macklin Biochemical Description and Business Overview
Table 117. Shanghai Macklin Biochemical Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 118. Shanghai Macklin Biochemical Ofatumumab Product
Table 119. Shanghai Macklin Biochemical Recent Developments/Updates
Table 120. Shanghai Yifei Biotechnology Corporation Information
Table 121. Shanghai Yifei Biotechnology Description and Business Overview
Table 122. Shanghai Yifei Biotechnology Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 123. Shanghai Yifei Biotechnology Ofatumumab Product
Table 124. Shanghai Yifei Biotechnology Recent Developments/Updates
Table 125. Tianmen Hengchang Chemical Corporation Information
Table 126. Tianmen Hengchang Chemical Description and Business Overview
Table 127. Tianmen Hengchang Chemical Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 128. Tianmen Hengchang Chemical Ofatumumab Product
Table 129. Tianmen Hengchang Chemical Recent Developments/Updates
Table 130. Wuhan Topule Biopharmaceutical Corporation Information
Table 131. Wuhan Topule Biopharmaceutical Description and Business Overview
Table 132. Wuhan Topule Biopharmaceutical Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 133. Wuhan Topule Biopharmaceutical Ofatumumab Product
Table 134. Wuhan Topule Biopharmaceutical Recent Developments/Updates
Table 135. Wuhan Wogeda Biotechnology Corporation Information
Table 136. Wuhan Wogeda Biotechnology Description and Business Overview
Table 137. Wuhan Wogeda Biotechnology Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 138. Wuhan Wogeda Biotechnology Ofatumumab Product
Table 139. Wuhan Wogeda Biotechnology Recent Developments/Updates
Table 140. Wuhan Yingnuo Pharmaceutical Technology Corporation Information
Table 141. Wuhan Yingnuo Pharmaceutical Technology Description and Business Overview
Table 142. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2019-2024)
Table 143. Wuhan Yingnuo Pharmaceutical Technology Ofatumumab Product
Table 144. Wuhan Yingnuo Pharmaceutical Technology Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Ofatumumab Distributors List
Table 148. Ofatumumab Customers List
Table 149. Ofatumumab Market Trends
Table 150. Ofatumumab Market Drivers
Table 151. Ofatumumab Market Challenges
Table 152. Ofatumumab Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ofatumumab
Figure 2. Global Ofatumumab Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Ofatumumab Market Share by Type in 2023 & 2030
Figure 4. Patent Product Picture
Figure 5. Generic Product Picture
Figure 6. Global Ofatumumab Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Ofatumumab Market Share by Application in 2023 & 2030
Figure 8. Chemical
Figure 9. Pharmaceutical
Figure 10. Global Ofatumumab Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Ofatumumab Market Size (2019-2030) & (US$ Million)
Figure 12. Global Ofatumumab Sales (2019-2030) & (Kg)
Figure 13. Global Ofatumumab Average Price (US$/Kg) & (2019-2030)
Figure 14. Ofatumumab Report Years Considered
Figure 15. Ofatumumab Sales Share by Manufacturers in 2023
Figure 16. Global Ofatumumab Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Ofatumumab Players: Market Share by Revenue in 2023
Figure 18. Ofatumumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Ofatumumab Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Ofatumumab Sales Market Share by Country (2019-2030)
Figure 21. North America Ofatumumab Revenue Market Share by Country (2019-2030)
Figure 22. United States Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Ofatumumab Sales Market Share by Country (2019-2030)
Figure 25. Europe Ofatumumab Revenue Market Share by Country (2019-2030)
Figure 26. Germany Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Ofatumumab Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Ofatumumab Revenue Market Share by Region (2019-2030)
Figure 33. China Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Ofatumumab Sales Market Share by Country (2019-2030)
Figure 43. Latin America Ofatumumab Revenue Market Share by Country (2019-2030)
Figure 44. Mexico Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Brazil Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Argentina Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Ofatumumab Sales Market Share by Country (2019-2030)
Figure 48. Middle East & Africa Ofatumumab Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Ofatumumab Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Ofatumumab by Type (2019-2030)
Figure 53. Global Revenue Market Share of Ofatumumab by Type (2019-2030)
Figure 54. Global Ofatumumab Price (US$/Kg) by Type (2019-2030)
Figure 55. Global Sales Market Share of Ofatumumab by Application (2019-2030)
Figure 56. Global Revenue Market Share of Ofatumumab by Application (2019-2030)
Figure 57. Global Ofatumumab Price (US$/Kg) by Application (2019-2030)
Figure 58. Ofatumumab Value Chain
Figure 59. Ofatumumab Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Distributors Profiles
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
